A significant advance in cancer study is arising with the use of nanobodies to reactivate mutated p53. This essential malignant inhibitor protein is frequently disabled in several forms of malignancies, causing https://210list.com/story22736000/mini-antibodies-revive-p53-the-potential-pathway-for-cancer-treatment